Hashtag
Men's Weekly

Crossing Borders Freely: Why Schengen Visa Multiple Entry is Built for Global Citizens

Your meetings are in Munich, your art show is in Paris, and your friends are waiting in Barcelona. You travel often—not for leis...

May Gibbs Foundation Launches New Online Store to Aid Cerebral Palsy Research

The May Gibbs Foundation, the legacy of Australian Children’s author May Gibbs, this month launches a new online store at maygib...

Renovating an Old Home? Here’s What You Should Fix First

Restoring an old house comes with flair and a few surprises. Although the temptation to jump straight into design improvements i...

How to Choose the Best Asbestos Removalist Melbourne for Your Construction Project

When planning a construction or renovation project in Melbourne, ensuring the safety of your site is paramount. One of the hidde...

How Does a Dual Battery System Actually Work

A dual battery system is essential for those who love off-grid adventures or need reliable power for work vehicles. It plays a cru...

What Makes a Power Pack Essential for Off-Grid Trips

Embarking on an off-grid adventure invites you to reconnect with nature, far from the convenience of the electric grid. Yet, stayi...


SINGAPORE - Media OutReach - 31 May 2023 - According to a recent study sponsored by Merck, a leading science and technology company, mRNA technology is a "game-changer" for Asia-Pacific (APAC) vaccine manufacturers. Nearly 40 manufacturers participated in the survey.

Filling of Merck
Filling of Merck's synthetic cholesterol, a key component of mRNA-based vaccines and therapeutics, at the company's Darmstadt facility

"Vaccine manufacturers in APAC are looking to build capacity for mRNA technology over the next two to three years, while continuing to produce both traditional and modern cell-based vaccines," said Josephine Cheng, Senior Consultant, Process Solutions APAC at the Life Science business sector of Merck. "Across APAC, governments are investing and supportive of driving therapeutic discovery and manufacturing. With the range of tools we offer, we can better equip vaccine manufacturers to treat the regional and global population."

The study interviewed vaccine manufacturers across APAC, including research institutes, pharmaceutical and biotech companies. Eighty-seven percent deemed mRNA a promising technology, expecting it to be a key modality in the future. This is based on the perception that the mRNA platform benefits from shorter development time and templated manufacturing processes, proven efficacy, lower biohazard risk for operators, and flexibility in covering different types of diseases and variants.

Japan, South Korea, Australia, Indonesia, Singapore, China and India are among the markets actively exploring to develop mRNA technology. Over sixty percent of the vaccine makers prefer to revamp or establish new facilities especially for mRNA with expansion planned over the next two to three years.

To effectively move mRNA forward, respondents highlighted the need for skilled personnel trained in these new technologies, tech-transfer expertise, a reliable supply chain, and mRNA-specific regulatory guidelines.

Merck’s contribution to future vaccine manufacturing
Merck's Life Science business supports mRNA manufacturers helping accelerate speed to market, ensuring safety and efficacy, to reducing complexity across the entire mRNA process to help accelerate delivery of mRNA vaccines to patients worldwide. More information is available on sigmaaldrich.com/vaccines
Hashtag: #Merck

The issuer is solely responsible for the content of this announcement.

Merck

Merck, a leading science and technology company, operates across life science, healthcare and electronics. More than 64,000 employees work to make a positive difference to millions of people's lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2022, Merck generated sales of € 22.2 billion in 66 countries.

Scientific exploration and responsible entrepreneurship have been key to Merck's technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as MilliporeSigma in life science, EMD Serono in healthcare, and EMD Electronics in electronics.

All Merck news releases are distributed by email at the same time they become available on the Merck website. Please go to to register online, change your selection or discontinue this service.

IN THE NEWS

"Sulfuric Fire Fishing" Tours Await Sustainability-Minded Visitors in Jinshan June-Sept

NEW TAIPEI CITY, TAIWAN - Media OutReach Newswire - 12 July 2024 – In tandem with the global push toward.

Porsche Design and Ananda Development Debut Asia's First Porsche Design Tower in Bangkok

BANGKOK, THAILAND/STUTTGART, GERMANY - Media OutReach Newswire - 27 August 2024 - Porsche Design has ann.

The Dos and Don'ts of Hair Washing: How Often Should You Shampoo Your Hair?

The shampoo industry is vast. The global shampoo market was worth over $30 billion in 2021 and is pre.

NUS expands start-up hub in Tokyo to propel deep tech innovation

BLOCK71 Tokyo, its second office in Japan, opens at TAKANAWA GATEWAY CITY, the country's latest g.

Over Ten Leading Products Launched, Humanoid Robots Steal the Spotlight -- Beijing E-Town Establishe…

BEIJING, CHINA - Media OutReach Newswire - 26 August 2024 - After achieving the world's first humanoid r.

Trend Micro Achieves Google Cloud Ready - Regulated & Sovereignty Solutions Designation

Expanded collaboration to accelerate market growth and unleash new opportunities HONG KONG SAR - Media O.

Health & Wellness

A Permanent Fix: Why More Patients Are Choosing Dental Implants

Hashtag.net.au - avatar Hashtag.net.au

Among the myriad of advancements in the field of dentistry, none have impacted as radically as dental implants. A last option not long ago, today, implants are the go-to solution for millions of ind...

Smile Confidently: Sydney's Best Cosmetic Dentists for Invisalign Treatment

Hashtag.net.au - avatar Hashtag.net.au

A warm, welcoming smile can change how you see yourself and how others see you. But to so many, crooked or uneven teeth will obstruct smiling openly. Modern cosmetic dentistry has answers, though, t...

Will Anyone Notice My Clear Aligners? Here’s the Honest Truth

Hashtag.net.au - avatar Hashtag.net.au

Image by freepikClear aligners have become hugely popular in Australia, promising discreet orthodontic treatment without the obvious look of metal braces. Yet, despite their growing popularity, a co...